Handling and safety of two insulin injection pens (FlexPen® and OptiClik®) in insulin-naive type 2 diabetes patients

被引：0
|
作者：
Asakura, Toshinari
Seino, Hiroaki
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A457 / A458
页数：2
相关论文
共 50 条
  • [41] Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone
    Liao Lin
    Yang Ming
    Qiu Lu-lu
    Mou Ya-ru
    Zhao Jia-jun
    Dong Jian-jun
    CHINESE MEDICAL JOURNAL, 2010, 123 (24) : 3684 - 3688
  • [42] Insulin Degludec Reduces Hypoglycemia and Improves Health Status vs. Insulin Glargine in Insulin-Naive Type 2 Diabetes
    Rodbard, Helena W.
    Handelsman, Yehuda
    Cariou, Bertrand
    Johansen, Thue
    Christensen, Torsten E.
    Mathieu, Chantal
    DIABETES, 2012, 61 : A307 - A308
  • [43] Once weekly basal insulin Fc demonstrated similar glycaemic control to once daily insulin degludec in insulin-naive patients with type 2 diabetes
    Bue-Valleskey, J. M.
    Kazda, C.
    Ma, C.
    Chien, J.
    Zhang, Q.
    Chigutsa, E.
    Landschulz, W.
    Swan, J.
    Haupt, A.
    Frias, J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S334 - S334
  • [44] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naive People with Type 2 Diabetes: the ATOS Study
    Galstyan, Gagik R.
    Tirosh, Amir
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen
    Coudert, Mathieu
    Naqvi, Mubarak
    Pilorget, Valerie
    Khan, Niaz
    DIABETES THERAPY, 2022, 13 (06) : 1187 - 1202
  • [45] Physical health status and nocturnal hypoglycaemia with insulin degludec vs insulin glargine: a 2-year trial in insulin-naive patients with type 2 diabetes
    Handelsman, Y.
    Cariou, B.
    Rodbard, H. W.
    Zinman, B.
    Wolden, M. L.
    Rana, A.
    Mathieu, C.
    DIABETOLOGIA, 2013, 56 : S422 - S422
  • [46] Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
    Rosenstock, Julio
    Bergenstal, Richard
    DeFronzo, Ralph A.
    Hirsch, Irl B.
    Klonoff, David
    Boss, Anders H.
    Kramer, David
    Petrucci, Richard
    Yu, Wen
    Levy, Brian
    DIABETES CARE, 2008, 31 (11) : 2177 - 2182
  • [47] Insulin Degludec Improves Glycemic Control in Insulin-Naive Patients With Type 2 Diabetes: Results of a Randomized Pan-Asian Trial
    Onishi, Yukiko
    Park, Sung Woo
    Yoo, Soon Jib
    Clauson, Per
    Tamer, Soren C.
    Iwamoto, Yasuhiko
    DIABETES, 2012, 61 : A272 - A272
  • [48] Triple therapy in type 2 diabetes - Insulin glargine or rosiglitazone added to combmiation therapy of sulfonylurea plus metformin in insulin-naive patients
    Rosenstock, J
    Sugimoto, D
    Strange, P
    Stewart, JA
    Soltes-Rak, E
    Dailey, G
    DIABETES CARE, 2006, 29 (03) : 554 - 559
  • [49] CONTRIBUTIONS OF AND RELATIONSHIP BETWEEN EXPECTATIONS ABOUT AND EXPERIENCES WITH INSULIN THERAPY TO TREATMENT SATISFACTION IN INSULIN-NAIVE PATIENTS WITH TYPE-2 DIABETES
    Naegeli, A. N.
    Hayes, R. P.
    VALUE IN HEALTH, 2009, 12 (03) : A105 - A105
  • [50] A randomized clinical trial of basal insulin peglispro vs NPH in insulin-naive patients with type 2 diabetes: the IMAGINE 6 trial
    Grunberger, G.
    Chen, L.
    Rodriguez, A.
    Tinahones, F. J.
    Jacober, S. J.
    Bue-Valleskey, J.
    DIABETES OBESITY & METABOLISM, 2016, 18 : 34 - 42
12345